JOSEPH CAPASSO: Open Payments
NPI 1780733279 · CEDAR HILL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,576 in 178 payments from 22 companies in 2025. Trend: 2023 $3,325 · 2024 $3,542 · 2025 $3,576
Food & beverage: $3,228Education: $348
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $473 |
| Galderma Laboratories, L.P. | 28 | $447 |
| Janssen Biotech, Inc. | 16 | $433 |
| Regeneron Healthcare Solutions, Inc. | 13 | $282 |
| ABBVIE INC. | 22 | $278 |
| Incyte Corporation | 13 | $234 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $202 |
| Novartis Pharmaceuticals Corporation | 11 | $201 |
| LEO Pharma Inc. | 9 | $172 |
| UCB, Inc. | 9 | $158 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, OPZELURA, COSENTYX, Bimzelx, ADBRY, SKYRIZI.
Industry payments across TX — which companies pay providers there.
